DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award
The FY24 ALSRP Therapeutic Development Award funds research for therapies targeting ALS, from preclinical validation to FDA IND-enabling studies. Projects should be empirical and product-focused, starting with lead compounds and proof-of-concept data in ALS models. Applicants are encouraged to collaborate with ALS experts. The grant supports the development of predictive biomarkers alongside t…
Source
Award
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
-
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers